Literature DB >> 7496196

[The detection of anti-galactocerebroside autoantibodies in human African trypanosomiasis].

P M Jauberteau1, S Bisser, Z Ayed, I Brindel, B Bouteille, A Stanghellini, S Gampo, F Doua, J C Breton, M Dumas.   

Abstract

The pathogenesis of the central nervous system (CNS) damage in human african trypanosomiasis (HAT) is unknown. In view of an immunological mechanism, as in another trypanosomiasis, Chagas' disease, the causative agent of which is Trypanosoma cruzi, we have searched autoantibodies directed against glycosphingolipids of CNS. Detection and characterization of autoantibodies were performed by ELISA and detection after thin-layer chromatography of glycolipids with sera of an experimental model of HAT in sheep and sera of patients suffering of HAT from Côte d'Ivoire and Congo. The predominant reactivity of these sera, was characterized with galactocerebrosides, the major glycolipids of the myelin. Autoantibodies were detected in 42.8% and 25% of patients' sera, respectively from Côte d'Ivoire and Congo. The proportion of these antibodies increased dramatically to 72% in sera of patients with neurological symptoms. Anti-galactocerebroside antibodies were also found in CSF of 24.4% of Congolense patients. The pathogenic significance of these anti-galactocerebroside antibodies remains to be determined. They may constitute a predicative marker for the neurological improvement in HAT.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496196

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  3 in total

1.  Dot enzyme-linked immunosorbent assay for more reliable staging of patients with Human African trypanosomiasis.

Authors:  Bertrand Courtioux; Sylvie Bisser; Pascal M'belesso; Edgard Ngoungou; Murielle Girard; Auguste Nangouma; Théophile Josenando; Marie-Odile Jauberteau-Marchan; Bernard Bouteille
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts.

Authors:  N Müller; J M Mansfield; T Seebeck
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

3.  Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.

Authors:  M Girard; S Bisser; P Buscher; B Bouteille; J L Preud'homme; M O Jauberteau
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.